Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA faults company behind recalled eye drops for multiple violations, bans imports

Por: CBS News Health February 03, 2023

thumbnail

The Food and Drug Administration announced Thursday that it has moved to restrict imports of products manufactured by an Indian healthcare firm, after it urged the company to recall eye drops of extensively drug-resistant bacteria across the country.Global Pharma Healthcare Private Limited produces artificial tears that are sold under the brand names EzriCare or Delsam Pharma, which are now all . The FDA cited multiple violations of... + full article



Similar News

House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug

Politico USA Health December 30, 2022

thumbnailThe FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más

Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times

Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News


For 1st Time Since 2014, U.S. Toy Imports Dip Below $2 Billion

Forbes USA Business December 24, 2022

thumbnailThe month of October is traditionally the busiest month for imports of children's toys — but not ... [+] this year.ustradenumbers.com For the first time this century, children’s toy imports did not peak in October, instead falling below $2 billion in an October for the... + más

A 100-Year Old Toy Story: How Pressman Toy Shaped The Business Of Play | Forbes

Will Kidults Save The Toy Industry This Christmas? | Forbes


Panel warns FDA’s beleaguered tobacco unit lacks direction

ABC News USA Health December 20, 2022

thumbnailWASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


Panel warns FDA’s beleaguered tobacco unit lacks direction

WPLG Local 10 USA Politics December 20, 2022

thumbnailWASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press


Despite Lousy Trade Policy, U.S. Imports To Top $3 Trillion For 2022

Forbes USA Business December 19, 2022

thumbnailChina is the leading importer into the United States but its percentage of the total is the lowest ... [+] since 2008.AFP via Getty Images U.S. imports are poised to top $3 trillion for the first time this year, . I already wrote that U.S. exports could top and that overall... + más

U.S. Total Trade Likely To Surpass Eye-Popping $5 Trillion In 2022 | Forbes

Japan racks up trade deficit as exports, imports hit records | ABC News


Panel warns FDA’s beleaguered tobacco unit lacks direction

Associated Press USA Politics December 19, 2022

thumbnailWASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10



About iurex | Privacy Policy | Disclaimer |